SCHEMBL6360973

SCHEMBL6360973

CC1CC=C(C(C)C)C(=O)C1

nearest known ligand 0.34

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.34
USP2 O75604 1/20 0.31
CSNK2A2 P19784 1/20 0.30
CSNK2B P67870 1/20 0.30
CSNK2A1 P68400 1/20 0.30
CSNK2A3 Q8NEV1 1/20 0.30
ABCG2 Q9UNQ0 1/20 0.30
EEF2K O00418 1/20 0.30
PLK1 P53350 1/20 0.30
PLK2 Q9NYY3 1/20 0.30
CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13261993 0.73
SCHEMBL5370411 0.73
SCHEMBL14816663 0.73
SCHEMBL18073587 0.71 PTPN1 (0.32) L3MBTL1USP2EEF2KPLK1PLK2
SCHEMBL1044726 0.67
SCHEMBL1781929 0.67 CCR2 (0.37)
SCHEMBL10626085 0.65 EEF2K (0.34) USP2EEF2KPLK1PLK2
SCHEMBL11124549 0.64
SCHEMBL7029411 0.64
SCHEMBL6548167 0.62 HIF1A (0.50) EEF2KPLK1PLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118460280-A Tea-flavored essence for cigarettes and preparation method thereof 山东中烟工业有限责任公司 2024-08-09 CN claimed
JP-55147234-A None JP disclosed
US-20260063603-A1 PROCESS FOR DIFFERENTIATION OF HIGH-VALUE NATURAL ESSENTIAL OIL-BASED AROMA CHEMICALS FROM SYNTHETIC ANALOGUES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2026-03-05 US disclosed
CN-118460280-A Tea-flavored essence for cigarettes and preparation method thereof 山东中烟工业有限责任公司 2024-08-09 CN disclosed
CN-117859944-A Low-temperature heating non-combustible tobacco particles and preparation method and application thereof 内蒙古昆明卷烟有限责任公司 2024-04-12 CN disclosed
CN-110191877-B Cleavable surfactants 弗门尼舍有限公司 2023-04-28 CN disclosed
US-9758645-B2 Use of a precipitated silica containing titanium and a specific coupling agent in an elastomer composition RHODIA OPERATIONS (FR) 2017-09-12 US disclosed
US-9758645-B2 Use of a precipitated silica containing titanium and a specific coupling agent in an elastomer composition RHODIA OPERATIONS (FR) 2017-09-12 US disclosed
EP-2851359-B1 METHOD FOR PRODUCING 4,4''-DIHYDROXY-M-TERPHENYLS HONSHU CHEMICAL IND (JP) 2017-03-29 EP disclosed
US-20150284546-A1 Use of a precipitated silica containing titanium and a specific coupling agent in an elastomer composition RHODIA OPERATIONS (FR) 2015-10-08 US disclosed
US-20120208975-A1 CONJUGATED DIENE PHOSPHINATE COMPOUNDS, PREPARATION METHOD AND USE THEREOF RHODIA (CHINA) CO., LTD. (CN) 2012-08-16 US disclosed
US-20120202957-A1 METHOD FOR PREPARING CONJUGATED DIENE PHOSPHONATE COMPOUNDS RHODIA (CHINA) CO., LTD. (CN) 2012-08-09 US disclosed
US-20120202957-A1 METHOD FOR PREPARING CONJUGATED DIENE PHOSPHONATE COMPOUNDS RHODIA (CHINA) CO., LTD. (CN) 2012-08-09 US disclosed
WO-2011050533-A1 METHOD FOR PREPARING CONJUGATED DIENE PHOSPHONATE COMPOUNDS RHODIA (CHINA) CO., LTD. (CN) 2011-05-05 WO disclosed
WO-2011050537-A1 CONJUGATED DIENE PHOSPHINATE COMPOUNDS, PREPARATION METHOD AND USE THEREOF RHODIA (CHINA) CO., LTD. (CN) 2011-05-05 WO disclosed
US-20050181080-A1 Chinese traditional medicines for psoriasis HUANG HSU-SHAN (TW) 2005-08-18 US disclosed
US-20030165533-A1 Chinese traditional medicines for psoriasis HUANG HSU-SHAN (TW) 2003-09-04 US disclosed
US-20030152588-A1 Chinese traditional medicines for psoriasis HUANG HSU-SHAN (TW) 2003-08-14 US disclosed
US-6121234-A ORALLY COADMINISTERING TO MAMMAL PHARMACEUTICAL COMPOUND AND ESSENTIAL OIL AVMAX, INC. (US) 2000-09-19 US disclosed
JP-S55147234-A PREPARATION OF (+)-2-ISOPROPYL-5-METHYL-CYCLOHEXANONE T HASEGAWA CO LTD 1980-11-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202957-A1 METHOD FOR PREPARING CONJUGATED DIENE PHOSPHONATE COMPOUNDS PHOSPHO1, PNKP, PIK3CA L3MBTL1 4727/4885USP2 3585/4885CSNK2A2 719/4885
US-20120208975-A1 CONJUGATED DIENE PHOSPHINATE COMPOUNDS, PREPARATION METHOD AND USE THEREOF ACSL3, INPPL1, FFAR3 L3MBTL1 2847/4885USP2 4443/4885CSNK2A2 2911/4885
US-20260063603-A1 PROCESS FOR DIFFERENTIATION OF HIGH-VALUE NATURAL ESSENTIAL OIL-BASED AROMA CHEMICALS FROM SYNTHETIC ANALOGUES SRMS, TRPM4, SMAD2 L3MBTL1 4359/4885USP2 4741/4885CSNK2A2 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.